Showing results (71-80 of 236) with videos related to

Sort By:
Pageof 24
Expert Review of Anti-Infective Therapy|April 10, 2013
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and managementJason M Pogue, Tal Mann, Katie E Barber, et al.
Infectious Diseases and Therapy|March 31, 2017
Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A ReviewJennifer N Lashinsky, Oryan Henig, Jason M Pogue, et al.
Infectious Diseases and Therapy|February 27, 2023
Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant EnterobacteralesKeith S Kaye, Thierry Naas, Jason M Pogue, et al.
Pharmacotherapy|September 5, 2014
Colistin: understanding and applying recent pharmacokinetic advancesJessica K Ortwine, Keith S Kaye, Jian Li, et al.
Antibiotics (Basel, Switzerland)|July 27, 2022
Empiric Usage of "Anti-Pseudomonal" Agents for Hospital-Acquired Urinary Tract InfectionsOri Rahat, Murad Shihab, Elhai Etedgi, et al.
Future Microbiology|March 14, 2017
Clinical and molecular epidemiology of Acinetobacter baumannii bloodstream infections in an endemic settingDror Marchaim, Dana Levit, Roy Zigron, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
The Epidemiology of Multidrug-Resistant Sepsis among Chronic Hemodialysis PatientsShani Zilberman-Itskovich, Yazid Elukbi, Roni Weinberg Sibony, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 13, 2012
Group B Streptococcus infections in non-pregnant adults: the role of immunosuppressionBharath Sunkara, Suchitha Bheemreddy, Bibi Lorber, et al.
Infection Control and Hospital Epidemiology|August 11, 2011
Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical centerDror Marchaim, Teena Chopra, Federico Perez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2023
Which trial do we need? Combination antimicrobial therapy for hospital-acquired bacterial pneumonia caused by Pseudomonas aeruginosaOwen R Albin, Jason M Pogue, Richard G Wunderink, et al.
Pageof 24